This study was designed to investigate effect of the HDAC3/miR‐495‐3p/TRAF5 axis in the development of melanoma, and we found that the inhibition of HDAC5 has the ability to elevate miR‐495‐3p to restrain the progression of melanoma by reducing TRAF5. Here, HDAC3 is linked to melanoma.